AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NOVA EYE MEDICAL LTD

0.132

+0.0021.54%

Volume:12.72K

Turnover:2K

Market Cap:37.60M

PE:-8.67

High:0.135

Open:0.135

Low:0.132

Close:0.130

52wk High:0.205

52wk Low:0.100

Shares:284.83M

Float Shares:240.54M

Volume Ratio:0.06

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.015

EPS(LYR):-0.015

ROE:-26.07%

ROA:-11.37%

PB:2.63

PE(LYR):-8.68

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Nova Eye Medical Ltd - Ebitda Positive of A$0.2 Mln in Six Months to 30 June 2026

THOMSON REUTERS

Nova Eye Medical Ltd - Guidance for FY27 Reaffirmed

THOMSON REUTERS

Nova Eye Medical Ltd - Full Year Sales of A$34.9 Mln up 26% in Constant Currency on Prior Year

THOMSON REUTERS

National Vision Holdings (EYE) Earnings Put Its Undervalued Narrative Back In Focus

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/EYE.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"EYE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EYE.AU\",,,,,undefined,":{"symbol":"EYE.AU","market":"AU","secType":"STK","nameCN":"NOVA EYE MEDICAL LTD","latestPrice":0.132,"timestamp":1789536157076,"preClose":0.13,"halted":0,"volume":12723,"delay":0,"changeRate":0.015384615384615398,"nameEN":"NOVA EYE MEDICAL LTD","floatShares":240542047,"shares":284833284,"eps":-0.015229,"marketStatus":"Trading","change":0.002,"latestTime":"09-16 15:23:44 AEST","open":0.135,"high":0.135,"low":0.132,"amount":1711,"amplitude":0.023077,"askPrice":0.135,"askSize":18923,"bidPrice":0.13,"bidSize":224545,"shortable":3,"etf":0,"ttmEps":-0.015229,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789538400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.13,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0.060194,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"EYE.AU","preClose":0.135,"auctionPrice":0.13,"auctionVolume":34581,"auction":3,"marketStatus":"盘后竞价","timestamp":1789452615337}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EYE.AU\",,,,,undefined,":{"symbol":"EYE.AU","floatShares":240542047,"roa":"-11.37%","roe":"-26.07%","lyrEps":-0.0152,"volumeRatio":0.060194,"shares":284833284,"dividePrice":0,"high":0.135,"amplitude":0.023077,"preClose":0.13,"low":0.132,"week52Low":0.1,"pbRate":"2.63","psRate":"1.08","week52High":0.205,"institutionHeld":0,"latestPrice":0.132,"committee":0.844555,"eps":-0.015229,"divideRate":0,"volume":12723,"delay":0,"ttmEps":-0.015229,"open":0.135,"prevYearClose":0.132,"prevWeekClose":0.14,"prevMonthClose":0.14,"prevQuarterClose":0.105,"fiveDayClose":0.14,"twentyDayClose":0.145,"sixtyDayClose":0.1,"dividendGrowthYears":0,"dividendGrowthRate":-1,"fiveYearAvgDividendRate":1.3621794871794872},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EYE.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-04","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785801600000,"name":null,"time":"","dateTimestamp":1785765600000,"actualEps":null},{"date":"2026-02-01","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1769900400000,"name":null,"time":"","dateTimestamp":1769864400000,"actualEps":null},{"date":"2025-10-27","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761519600000,"name":null,"time":"","dateTimestamp":1761483600000,"actualEps":null},{"market":"AU","date":"2024-02-13","symbol":"EYE.AU","defaultRemindTime":1707778800000,"type":"split","dateTimestamp":1707742800000,"forFactor":973737,"toFactor":1000000,"ratio":0.973737},{"date":"2023-08-28","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693180800000,"name":null,"time":"","dateTimestamp":1693144800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EYE.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-07-21","recordDate":"2020-07-22","paymentDate":"2020-07-29","value":0.135,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EYE.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662982627","title":"Nova Eye Medical Ltd - Ebitda Positive of A$0.2 Mln in Six Months to 30 June 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662982627","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662982627?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:04","pubTimestamp":1787727875,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0DW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EYE.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662798293","title":"Nova Eye Medical Ltd - Guidance for FY27 Reaffirmed","url":"https://stock-news.laohu8.com/highlight/detail?id=2662798293","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662798293?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:04","pubTimestamp":1787727875,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EYE.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662798267","title":"Nova Eye Medical Ltd - Full Year Sales of A$34.9 Mln up 26% in Constant Currency on Prior Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2662798267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662798267?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:04","pubTimestamp":1787727875,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0DW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","EYE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662476287","title":"National Vision Holdings (EYE) Earnings Put Its Undervalued Narrative Back In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2662476287","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662476287?lang=en_us&edition=fundamental","pubTime":"2026-08-26 11:29","pubTimestamp":1787714966,"startTime":"0","endTime":"0","summary":"National Vision Holdings (EYE) drew fresh attention on August 12 after reporting higher second quarter revenue of $498.81 million and net income of $12.42 million, along with updated full year guidance and a completed share repurchase tranche.\nAt a share price of $18.69, National Vision Holdings has seen a 1-day share price return of 2.52%, while the 30-day share price return is down 6.17% and the year-to-date share price return is down 27.98%, pointing to fading momentum despite a 12.66%...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4444000-choice2-main-header/1585186827172"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/national-vision-holdings-eye-earnings-put-its-undervalued-na","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/retail/nasdaq-eye/national-vision-holdings/news/national-vision-holdings-eye-earnings-put-its-undervalued-na","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EYE","EYE.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EYE.AU\",params:#limit:6,delay:true,,,undefined,":[]}}